| __timestamp | ADMA Biologics, Inc. | Cytokinetics, Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 17268000 |
| Thursday, January 1, 2015 | 6745968 | 19667000 |
| Friday, January 1, 2016 | 8494742 | 27823000 |
| Sunday, January 1, 2017 | 18092835 | 36468000 |
| Monday, January 1, 2018 | 22502922 | 31282000 |
| Tuesday, January 1, 2019 | 25910757 | 39610000 |
| Wednesday, January 1, 2020 | 35050817 | 52820000 |
| Friday, January 1, 2021 | 42896889 | 96803000 |
| Saturday, January 1, 2022 | 52458024 | 177977000 |
| Sunday, January 1, 2023 | 59020000 | 173612000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, operational costs play a pivotal role in shaping a company's financial health. Over the past decade, Cytokinetics, Incorporated and ADMA Biologics, Inc. have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Cytokinetics saw a staggering 900% increase in SG&A expenses, peaking in 2022. This reflects their aggressive expansion and investment in research and development. In contrast, ADMA Biologics experienced a more moderate growth of approximately 1,100%, indicating a steady scaling of operations.
The year 2021 marked a significant leap for Cytokinetics, with expenses nearly doubling from the previous year, highlighting a strategic pivot. Meanwhile, ADMA's consistent growth underscores a balanced approach to managing operational costs. These trends offer a glimpse into the strategic priorities and market positioning of these biotech players.
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Cytokinetics, Incorporated
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Genmab A/S or Cytokinetics, Incorporated
SG&A Efficiency Analysis: Comparing Incyte Corporation and ADMA Biologics, Inc.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Galapagos NV